KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: An immunohistochemical analysis

Cancer

Volumn 83, Issue 3, 1998, Pages 466-474

  Higashiyama, Masahiko ^a   Kodama, Ken ^a   Yokouchi, Hideoki ^a   Takami, Koji ^a   Adachi, Masashi ^b   Taki, Toshihiko ^b   Ishiguro, Shingo ^a   Nakamori, Shoji ^a   Yoshie, Osamu ^c   Miyake, Masayuki ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Kitano Hospital   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

Immunohistochemistry; KAI1 CD82; Metastasis suppressor gene; Nonsmall cell lung carcinoma; Prognosis

Indexed keywords

CELL MEMBRANE PROTEIN; GENE PRODUCT; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KANGAI-1 PROTEIN; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE;

EID: 15444349774     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980801)83:3<466::AID-CNCR15>3.0.CO;2-U     Document Type: Article

References (27)

1. Dong J-T, Lamb PW, Rinker-Schaeffer CW, Yukanovic J, Ichikawa T, Isaacs JT, et al. KAI-1, a metastatic suppressor gene for prostatic cancer on human chromosome 11p11.2. Science 1995;268:884-6.
2. Gaugitsch HW, Hofer E, Huber NE, Schnabl E, Baumruker T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schitosoma mansoni antigen Sm23. Eur J Immunol 1991;21:377-83.
3. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Hinuma Y, et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive cells. J Virol 1992;66:1394-401.
4. Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, et al. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 1992;149:2879-86.
5. Imai T, Yoshie O. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol 1993;151:6470-81.
6. Wright MD, Tomlinson MG. The ins and outs of the transmembrane-4 superfamily. Immunol Today 1995;15:588-94.
7. Horejsi V, Vlcek C. Novel structurally distinct family of leukocyte surface glycoproteins including CD9, CD37, CD53, and CD63. FEBS Lett 1991;288:1-4.
8. Ueda T, Ichikawa T, Tamaru J, Mikata A, Akakura K, Akimoto S, et al. Expression of the KAIl protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol 1996;149: 1435-40.
9. Dong J-T, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 1996;56:4387-90.
10. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Kore M, et al. KAI1 expression id up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996;56:4876-80.
11. Yu Y, Yang J-L, Markovic B, Jackson P, Yardley G, Barrett J, et al. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 1997;3:1056-9.
12. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL, KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997;119:149-55.
13. Adachi M, Taki T, Ieki Y, Huang C-L, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis of patients with non-small cell lung cancer. Cancer Res 1996;56:1751-5.
14. American Joint Committee on Cancer, Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for Staging of Cancer, 4th edition. Philadelphia: J.B. Lippincott, 1992:115-22.
15. Miyake M, Koyama M, Seno M, Ikeyama S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 1991;174:1347-54.
16. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993;177:1231-7.
17. Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma, Int J Cancer 1993;54:37-43.
18. Miyake M, Nakano K, Ieki Y, Adachi M, Hunang C-L, Itoi S, et al. Motility related protein-1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 1995;55:4127-31.
19. Higashiyama M, Taki T, Adachi M, Huang C-L, Koh T, Kodama K, et al. Reduced-motility-related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 1995;55:6040-4.
20. Classon BJ, Williams AF, Willis AC, Seed B, Stamenkovic I. The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med 1989;169:1497-502.
21. Amiot M. Identification and analysis of cDNA clones encoding CD53: a pan-leukocyte antigen related to membrane transport proteins. J Immunol 1990;145:4322-5.
22. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, et al. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 1988;48:2955-62.
23. Oren R, Takahashi S, Doss C, Levy R, Levy S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 1990;10:4007-15.
24. Sincock PM, Mayrhofer G, Ashman LK. Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissue: comparison with CD9, CD63, and ∂5β1 integrin. J Histochem Cytochem 1997;45: 515-25.
25. Szala S, Kasai Y, Steplewski Z, Rodeck U, Koprowski H, Linnenbach AJ. Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigen. Proc Natl Acad Sci U S A 1990;87:6833-7.
26. Wright MD, Henkle KJ, Mitchell GF. An immunogenic Mr-23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen. J Immunol 1990;144:3195-200.
27. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, et al. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 1994;54:6249-56.